Related Experiment Video
Updated: Jan 5, 2026

A Plasma Sample Preparation for Mass Spectrometry using an Automated Workstation
Published on: April 24, 2020
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major
Sonia de Halleux1, Enrico Stura, Luc VanderElst
1Center for Molecular and Vascular Biology, University of Leuven, Belgium.
Background:
Der p 1 is a 25-kd allergen with cysteine protease activity. Sensitization to Der p 1 affects a large proportion of individuals with allergy, resulting in rhinitis, asthma, and/or atopic dermatitis.
Objective:
We determined the Der p 1 crystallographic structure to understand the relationships among structure, function, and allergenicity.
Methods:
Recombinant pro-Der p 1 was produced in Pichia pastoris and allowed to mature spontaneously before purification by a 2-step procedure. Protease activity was checked by using a fluorogenic peptide substrate. Allergenicity was analysed by IgE binding assays and basophil activation test. The determination of the 3-dimensional structure was obtained by X-ray crystallography at 1.9 A resolution.
Results:
The recombinant protein is fully active and expresses an allergenicity equivalent to its natural counterpart. Der p 1 exhibits a cysteine protease fold typical of the papain family, has a magnesium binding site, and forms dimers with a large interface. The crystal lattice shows that the dimers are tightly packed in a compact double layer of proteins. Such an assembly likely exists in dry fecal pellets, the natural form of allergen exposure, and appears ideal to interact with cell surface and trigger allergic inflammation.
Conclusion:
We present here the 3-dimensional structural features of mature fully active Der p 1, one of the main allergens involved in human allergic diseases. This opens the possibility to evaluate the importance of enzymatic activity in pathology and possible new therapeutic interventions.
Related Concept Videos
06:36Treating Surfaces with a Cold Atmospheric Pressure Plasma using the COST-Jet
07:12A Plasma Sample Preparation for Mass Spectrometry using an Automated Workstation
07:37Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
09:58Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
13:17Manufacture of Concentrated, Lipid-based Oxygen Microbubble Emulsions by High Shear Homogenization and Serial Concentration

